Cash Rich, Low Price – EPAM Systems Stock to Break Out?
EPAM Systems stock is presented as a potential investment opportunity due to its strong cash flow yield of 11.3%, 14.2% revenue growth over the last twelve months, and significant discount from its historical highs. The article suggests that companies with such characteristics can use cash to drive further growth or return value to shareholders, making them attractive. While highlighting the potential, it also advises understanding the risks involved, noting the stock's behavior during past market crashes and suggesting diversified portfolios over single stock trades.
Mettler-Toledo International Stock Testing Price Floor – Buy Now?
Mettler-Toledo International (MTD) stock is currently trading in a support zone from which it has historically bounced, generating significant peak returns. Despite a recent 15% stock drop due to macro jitters, analysts maintain "Buy" ratings with a median price target of $1,445, implying substantial upside. The company's strong Q1 2026 earnings, raised full-year EPS guidance, and sector tailwinds in the life science tools market suggest a likely rebound, though historical data also shows the stock is susceptible to significant dips during market downturns.
Mettler-Toledo International Inc. stock outperforms competitors on strong trading day
Shares of Mettler-Toledo International Inc. (MTD) rose 1.60% to $1,041.91 on Thursday, outperforming the broader market indexes like the S&P 500 and Dow Jones Industrial Average. This gain ended a five-day losing streak for the stock.
[Form 4] METTLER TOLEDO INTERNATIONAL INC/ Insider Trading Activity
Richard Ann Ping Wong, Head of Asia & Pacific at METTLER TOLEDO INTERNATIONAL INC (MTD), received a compensation-related equity grant consisting of 103 shares of common stock and options for 255 shares with an exercise price of $1,072.45.
METTLER TOLEDO (MTD) CFO granted shares and 720 stock options
METTLER TOLEDO INTERNATIONAL INC's Chief Financial Officer, Shawn Vadala, received equity-based compensation on May 12, 2026. This included a grant of 291 shares of common stock, bringing his total direct holdings to 5,579 shares, and 720 stock options with an exercise price of $1,072.45 per share. The options will vest annually in five equal installments starting one year from the grant date and will expire on May 12, 2036.
METTLER TOLEDO (MTD) executive receives stock grant and options award
Gerry Keller, an executive at METTLER TOLEDO INTERNATIONAL INC (MTD), has been granted 100 shares of common stock and options on 250 shares. This transaction brings his direct holdings to 259 shares, with the options having an exercise price of $1072.45 per share and vesting in five equal annual installments starting one year after the grant date. The equity awards are compensation-related grants, not open-market purchases.
Mettler-Toledo (MTD) CEO receives stock grant and 2,005 options
Mettler-Toledo (MTD) CEO Patrick Kaltenbach was granted 810 shares of common stock and options for 2,005 shares, as stated in a recent SEC Form 4 filing. The common shares were acquired at no cost, increasing his direct holdings to 4,480 shares. The stock options have an exercise price of $1,072.45 per share and will vest in five equal annual installments.
Mettler Toledo (NYSE: MTD) awards CHRO new shares and stock options
Mettler Toledo's Chief Human Resources Officer, Susan Graham-Bryce, was granted 71 shares of common stock and stock options for 175 shares with an exercise price of $1072.45. The options vest annually in five equal installments beginning on the first anniversary of the grant date and expire on May 12, 2036. Following this equity compensation, Graham-Bryce directly holds 517 common shares in the company.
Between Mettler-Toledo International and Thermo Fisher Scientific, Which Stock Looks Set to Break Out?
The article poses a question asking whether Mettler-Toledo International or Thermo Fisher Scientific is poised for a breakout in their stock performance. However, the provided content only contains navigation, disclaimers, and technical information related to an interactive model, without any actual analytical text or data comparing the two companies. Therefore, no substantive information regarding the stocks is present.
Mettler-Toledo International Stock 5-Day Losing Spree: Stock Falls -23%
Mettler-Toledo International (MTD) experienced a 5-day losing streak, with cumulative losses of 23% and a market cap reduction of $6.1 billion. Despite moderate operating performance, the stock is considered unattractive due to high valuation. The article suggests that such market movements are already priced in and highlights the need for predictive signals over notifications to manage individual stock risk.
Mettler-Toledo International Stock Slides 23% With A 5-Day Losing Spree
Mettler-Toledo International (NYSE: MTD) stock has experienced a significant decline, sliding 23% and enduring a five-day losing streak. The article headline indicates this substantial drop in the company's stock performance.
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
Shares of several healthcare and life sciences companies, including GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo, declined after an April PPI report indicated accelerating wholesale inflation, particularly in the service sector. This inflation could increase operating costs for healthcare providers and intensify calls for regulatory intervention on drug pricing. The article highlights that despite the drops, these movements could present buying opportunities for high-quality stocks.
Mettler-Toledo International Inc. stock underperforms Wednesday when compared to competitors
Mettler-Toledo International Inc. (MTD) stock declined by 4.38% on Wednesday, closing at $1,025.53. This underperformance occurred during a mixed trading session where the S&P 500 Index rose, but the Dow Jones Industrial Average fell. The stock experienced its fifth consecutive day of losses.
Mettler Toledo grants 2026 long-term incentives to Patrick Kaltenbach and Shawn P. Vadala
Mettler Toledo approved 2026 long-term incentive awards for key executive officers, including CEO Patrick Kaltenbach and CFO Shawn P. Vadala. These awards are split between May and November 2026, with the May grants detailed for several executives. The CEO's target LTI value increased by approximately 6.25% versus 2025, while NEOs' target LTI value saw an approximate 12.5% increase.
Mettler-Toledo (MTD) revises 2026 executive equity mix and grant timing
Mettler-Toledo International Inc. (MTD) has revised its 2026 long-term incentive awards for named executive officers, implementing a bifurcated grant structure with awards distributed in May and November 2026. Each award is now equally split among performance share units, non-qualified stock options, and restricted stock units, with unchanged vesting for performance units and options, and a three-year cliff vest for RSUs. The changes include an approximate 6.25% increase in the CEO's target LTI value and a 12.5% increase for other named executives compared to 2025.
How Danaher’s New Euro Debt, Dividend and Conferences At Danaher (DHR) Has Changed Its Investment Story
Danaher Corporation recently issued €3.00 billion in senior notes, affirmed its quarterly dividend, and participated in industry conferences, indicating management's confidence and long-term focus. This activity, particularly the debt issuance for the Masimo acquisition, impacts Danaher’s investment narrative by increasing financial commitments and highlighting execution risks related to leverage and market pressures. Despite varied fair value estimates, the financing sharpens focus on sustainable growth amidst potential funding challenges for life sciences customers.
Morgan Stanley Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Cuts Target Price to $1,078.53
Morgan Stanley analyst Kallum Titchmarsh has reiterated a "Hold" rating for Mettler-Toledo International (MTD.US) but has significantly lowered the target price from $1,475 to $1,078.53. According to TipRanks data, the analyst has a 34.3% success rate and an average return of -0.8% over the past year. This adjustment in target price reflects a revised outlook from Morgan Stanley on Mettler-Toledo International.
Morgan Stanley Lowers Mettler-Toledo International (NYSE:MTD) Price Target to $1,275.00
Morgan Stanley has reduced its price target for Mettler-Toledo International (NYSE:MTD) to $1,275.00 from $1,475.00, maintaining an "equal weight" rating despite a potential upside of 17.78%. Other analysts, including JPMorgan and Robert W. Baird, have also trimmed their expectations, contributing to a cautious near-term outlook for the stock, currently rated as a "Moderate Buy." The company recently reported Q1 earnings of $8.91 EPS, beating analyst estimates, with revenue also slightly exceeding expectations.
Morgan Stanley Cuts Price Target on Mettler-Toledo International to $1,275 From $1,475, Keeps Equalweight Rating
Morgan Stanley has lowered its price target for Mettler-Toledo International (MTD) to $1,275 from $1,475, while maintaining an Equalweight rating on the stock. This adjustment comes amidst a series of similar actions by other financial institutions, including Baird, JPMorgan, and Wells Fargo, all of whom have also reduced their price targets for the company. The article also notes Mettler-Toledo's recent Q1 2026 earnings report, which indicated a rise in earnings and revenue.
Mettler-Toledo forecasts $46.30-$46.95 adjusted EPS in 2026 while keeping ~4% local-currency sales growth
Mettler-Toledo International Inc. (NYSE: MTD) is projecting adjusted earnings per share between $46.30 and $46.95 for the fiscal year 2026. This forecast is based on an expected local-currency sales growth of approximately 4%.
Mettler-Toledo International Inc (MTD) Stock Down 4.1% -- Now Un
Mettler-Toledo International Inc (MTD) saw its stock fall by 4.1% to $1078.53, making it significantly undervalued according to GuruFocus' GF Value™ which estimates a fair value of $1422.89. The company boasts a high GF Score™ of 95/100, driven by strong profitability and growth, despite having a moderate financial strength rating. No insider transactions have occurred recently, suggesting insider confidence or stability.
Mettler-Toledo Shareholders Approve Directors and Executive Pay
Mettler-Toledo shareholders elected nine directors to one-year terms and ratified PwC as the company's independent auditor at their annual meeting on May 7, 2026. They also approved the firm's executive compensation program in a non-binding advisory vote. TipRanks' AI Analyst, Spark, rated MTD as "Neutral" due to high-margin profitability and strong free cash flow offset by elevated financial risk and demanding valuation.
Mettler-Toledo shareholders elect directors and approve auditor at annual meeting
Mettler-Toledo International Inc. (NYSE:MTD) shareholders held their annual meeting, electing nine directors for one-year terms. They also ratified PricewaterhouseCoopers LLP as the independent auditor and conducted an advisory vote on executive compensation. The meeting achieved a quorum with a significant majority of shares represented.
Mettler-Toledo (NYSE: MTD) investors approve board slate and say-on-pay
Mettler-Toledo International Inc. stockholders approved all nine director nominees, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and gave advisory approval to the company's executive compensation program at their annual meeting on May 7, 2026. A quorum was established with 18,545,318 shares represented out of 20,248,505 eligible common shares. All proposals received significantly more votes in favor than against.
JPMorgan Chase & Co. Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price
JPMorgan Chase & Co. has lowered its price target for Mettler-Toledo International (NYSE:MTD) from $1,413 to $1,200, maintaining a "neutral" rating despite other analysts having mixed views. The stock experienced a sharp decline, nearing its 52-week low, even though the company surpassed recent quarterly EPS and revenue estimates and provided strong FY 2026 guidance. Mettler-Toledo International currently holds an average "Moderate Buy" rating from analysts with a consensus target price of $1,437.
Mettler-Toledo stock hits 52-week low at 1096.07 USD
Mettler-Toledo International Inc. (MTD) stock has fallen to a 52-week low of 1096.07 USD, with a nearly 11% decline in the past week and 19% year-to-date. Despite beating first-quarter 2026 earnings expectations, the stock's decline is attributed to broader market concerns and future guidance challenges. InvestingPro analysis suggests the stock may be undervalued, holding a market cap of $22.2 billion.
Mettler-Toledo International Inc. stock underperforms Monday when compared to competitors
Mettler-Toledo International Inc.'s stock (MTD) declined by 4.08% on Monday, closing at $1,078.53, despite a generally positive trading session for the broader market. This marked the third consecutive day of losses for the company, while indices like the S&P 500 and Dow Jones Industrial Average saw gains.
Mettler-Toledo International (NYSE:MTD) Sets New 12-Month Low After Analyst Downgrade
Mettler-Toledo International (NYSE:MTD) hit a new 52-week low after Robert W. Baird lowered its price target from $1,445 to $1,194, maintaining a neutral rating. Despite this, the company reported better-than-expected quarterly earnings with EPS of $8.91 and revenue up 7.2% year over year, and analysts still maintain a "Moderate Buy" consensus rating with a target price of $1,444.08. Insiders and institutional investors have recently made adjustments to their holdings in the company.
Baird Adjusts Price Target on Mettler-Toledo International to $1,194 From $1,445
Baird has adjusted its price target for Mettler-Toledo International (NYSE:MTD) to $1,194, down from the previous target of $1,445. Despite the reduction, the firm maintained an "Outperform" rating on the stock. This revision reflects Baird's updated outlook for Mettler-Toledo International.
Mettler-Toledo International (NYSE:MTD) Price Target Lowered to $1,194.00 at Robert W. Baird
Robert W. Baird lowered its price target for Mettler-Toledo International (NYSE:MTD) to $1,194 from $1,445, while maintaining a "neutral" rating. Despite the reduction, the new target still suggests a 6.3% upside from the current share price. The company recently reported better-than-expected Q1 earnings with EPS of $8.91 and revenue of $947.13 million, and provided strong FY 2026 guidance.
Wells Fargo Adjusts Price Target on Mettler-Toledo International to $1,225 From $1,450
Wells Fargo has lowered its price target for Mettler-Toledo International (MT) to $1,225 from $1,450. This adjustment comes amidst other analyst revisions, including Citigroup and Evercore ISI also lowering their price targets for the company. The article also provides a brief overview of Mettler-Toledo International's business segments and recent financial performance.
Crossmark Global Holdings Inc. Acquires 1,060 Shares of Mettler-Toledo International, Inc. $MTD
Crossmark Global Holdings Inc. has increased its stake in Mettler-Toledo International by 34.3% in the fourth quarter, purchasing an additional 1,060 shares, bringing its total holdings to 4,150 shares valued at approximately $5.79 million. This occurred despite Mettler-Toledo reporting mixed Q1 results, with adjusted EPS and revenue slightly beating estimates, but Q2 EPS guidance falling below Wall Street expectations. The company currently holds a "Moderate Buy" rating from analysts with an average price target of $1,447.08.
Evolus May 2026 slides: HA innovation, Jeuveau data support dual strategy
Evolus Inc. presented comprehensive clinical data for its Evolysse hyaluronic acid filler line, featuring its proprietary Cold-X™ Technology, and its Jeuveau neuromodulator. The company highlighted strong efficacy and safety profiles for both product lines in various aesthetic indications, including statistical superiority for Evolysse Form against a comparator. Evolus also discussed an extra-strength Jeuveau formulation and outlined its commercial roadmap for upcoming product launches, reinforcing its dual-product strategy and positive market outlook.
Mettler Toledo (MTD) Margin Slippage Tests Bullish Earnings Growth Narratives
Mettler-Toledo International (MTD) closed FY 2025 with strong revenue and EPS, though overall net margins experienced a slight dip. This margin slippage, alongside a slower earnings growth rate compared to its five-year average, tests the bullish narrative of sustained growth driven by automation and services, particularly concerning expected margin expansion. While the company's valuation appears favorable compared to peers, it trades above its DCF fair value, indicating mixed signals for investors assessing the long-term outlook.
Mettler-Toledo International, Inc. $MTD Shares Sold by ASR Vermogensbeheer N.V.
ASR Vermogensbeheer N.V. significantly reduced its stake in Mettler-Toledo International (NYSE: MTD) by 38.3% in the fourth quarter, selling 1,579 shares and valuing its remaining 2,540 shares at approximately $3.54 million. Despite Mettler-Toledo beating first-quarter adjusted EPS and revenue expectations, its second-quarter EPS guidance fell below Wall Street estimates, potentially impacting the stock. Analysts largely maintain a "Moderate Buy" rating for the medical instruments supplier, with an average target price of $1,447.08.
A Look At Mettler Toledo (MTD) Valuation After Raised EPS Guidance And Strong Q1 2026 Results
Mettler-Toledo International (MTD) is garnering investor attention after reporting strong Q1 2026 results, including higher net sales, year-on-year EPS growth, and raised full-year EPS guidance. Despite a year-to-date stock decline of 6.5%, the company has seen a 12-month return of almost 20% and trades below the average analyst price target. Analysts view MTD as 11.4% undervalued, projecting a fair value of $1,488.31 due to long-term demand for its precision instruments, largely driven by expansion in the pharmaceutical, biopharma, and food production sectors.
Mettler-Toledo International, Inc. $MTD Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 4.0% in the fourth quarter, now owning 43,812 shares valued at $61.84 million. Other institutional investors have also adjusted their positions in the medical instruments supplier. The article also details recent analyst ratings, MTD's price performance, its latest quarterly earnings, and recent insider trading activity.
Evercore ISI Adjusts Price Target on Mettler-Toledo International to $1,300 From $1,425
Evercore ISI has revised its price target for Mettler-Toledo International (NYSE:MTD) shares, lowering it to $1,300 from the previous $1,425. The firm has maintained its "In-Line" rating on the stock. Mettler-Toledo International closed the previous trading session at $1,215.11.
Mettler-Toledo International Inc (MTD) Shares Fall 14.8% -- What GF Score of 94 Tells Investors
Mettler-Toledo International Inc (MTD) shares recently dropped 14.8% to $1124.46, yet the stock is considered "Modestly Undervalued" with a GF Value™ of $1444.71, suggesting a 22.2% upside. Despite a strong GF Score™ of 94/100, driven by perfect scores in Profitability and Valuation, insider selling of $1.1 million over the last three months raises a cautionary flag for potential investors. The current P/E of 26.4x is also significantly below its 5-year median, further indicating an undervalued status.
Citigroup Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,550.00
Citigroup has lowered its price target for Mettler-Toledo International (NYSE:MTD) to $1,550.00 from $1,700.00, while maintaining a "buy" rating on the stock. Despite the reduction, this new target still suggests a potential upside of approximately 38% from the stock's current trading price. This adjustment follows the company's recent quarterly earnings report, which exceeded analyst expectations for both EPS and revenue, and after which the stock experienced a significant drop.
Citigroup Adjusts Mettler-Toledo International PT to $1,550 From $1,700
Citigroup has lowered its price target for Mettler-Toledo International (NYSE: MTD) to $1,550 from $1,700. Despite the reduced price target, the firm maintains a "Buy" rating on the stock. This adjustment reflects a revised valuation perspective while still recommending the stock to investors.
Mettler-Toledo Q1 Earnings Top Estimates, Sales Increase Y/Y
Mettler-Toledo (MTD) reported strong first-quarter 2026 results, with adjusted earnings of $8.91 per share surpassing Zacks Consensus estimates by 2.44% and increasing 8.8% year-over-year. Net sales rose 7% to $947.1 million, also beating estimates. The company provided Q2 and full-year 2026 guidance, reaffirming sales growth expectations and raising its adjusted earnings outlook, despite acknowledging uncertain market conditions.
Mettler-Toledo International Inc. stock underperforms Friday when compared to competitors
Mettler-Toledo International Inc. (MTD) saw its stock price drop by 14.77% on Friday, despite a generally positive trading session for the broader market. The S&P 500 and Dow Jones Industrial Average both showed gains, indicating Mettler-Toledo's underperformance relative to its competitors. This marks the second consecutive day of losses for the company's stock.
Mettler-Toledo (NYSE: MTD) grows Q1 2026 sales but sees margin pressure
Mettler-Toledo International Inc. (NYSE: MTD) reported increased Q1 2026 sales to $947.1 million, up from $883.7 million in Q1 2025, with net earnings rising to $169.5 million. Despite this growth, the company experienced margin pressure, with gross margin slightly declining to 58.7% due to higher tariff costs, unfavorable currency, and business mix. MTD also continued its share repurchase program, buying back $206.3 million worth of shares, and noted potential tariff refunds of approximately $53 million following a U.S. Supreme Court decision.
Mettler-Toledo International Plunges 13.4% Amid Sector-Wide Selling
Mettler-Toledo International Inc. (MTD) experienced a significant 13.4% drop in its stock price, closing at $1142.39, as the diagnostics and research sector faced a broad selloff. While other companies in the sector saw smaller declines, Mettler-Toledo's steeper fall, despite no apparent company-specific news, suggests potential technical factors or a reassessment of valuations. Investors should monitor whether this sector-wide weakness persists and look for any company-specific information that might explain the substantial decline.
Mettler-Toledo International Plunges 13.4% Amid Sector-Wide Selling
Mettler-Toledo International Inc. (MTD) plunged 13.4% to close at $1142.39, driven by a broad selloff in the diagnostics and research sector. Despite the sector-wide decline, MTD's drop significantly outpaced its peers without any apparent company-specific news. Investors are urged to monitor whether sector weakness persists and if any specific catalyst emerges to explain the substantial decline.
KeyBanc Cuts McDonald’s Price Target to $330 as April Softness Tests the Recovery Thesis
KeyBanc analyst Eric Gonzalez has lowered the price target for McDonald's (MCD) to $330 from $345, while maintaining an Overweight rating. This adjustment follows McDonald's Q1 2026 earnings and is attributed to April sales softness, which KeyBanc believes is temporary and due to strong year-over-year comparisons from April 2025. Despite the price target cut, the firm remains confident in McDonald's recovery thesis, highlighting the company's value-led strategy, strong Q1 performance, and loyalty program growth.
Earnings call transcript: Mettler-Toledo Q1 2026 beats expectations; stock tumbles
Mettler-Toledo International Inc. (MTD) reported Q1 2026 adjusted EPS of $8.91 and revenue of $947 million, exceeding analyst forecasts. Despite beating expectations, the company's stock experienced a significant premarket decline of 13.27%, attributed to broader market concerns and cautious future guidance. The company highlighted strong growth in bioprocessing and industrial segments, while facing challenges from tariff impacts and macroeconomic uncertainties.
Mettler-Toledo International Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:MTD) 2026-05-08
Mettler-Toledo International Inc. (NYSE:MTD) reported its Q1 2026 earnings, with an EPS of $8.91, beating estimates by $0.20, and revenue of $947.13M, surpassing expectations by $6.10M and showing a 7.17% year-over-year increase. The company published a slide deck in conjunction with its earnings call. This article was prepared by Seeking Alpha's transcripts team.
Swedbank AB Grows Position in Mettler-Toledo International, Inc. $MTD
Swedbank AB increased its stake in Mettler-Toledo International, Inc. by 15.3% in the fourth quarter of 2025, bringing its total holdings to 22,705 shares valued at approximately $31.66 million. Mettler-Toledo reported strong quarterly earnings, beating analyst expectations with an EPS of $8.91 and revenue of $947.13 million, and provided optimistic guidance for FY2026. The stock currently holds a consensus "Moderate Buy" rating with a target price of $1,459.58, following recent analyst upgrades.
